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Introduction: Chronic stress can inﬂuence immune response to vaccines. Healthcare workers
are  exposed to stressors and biological hazards, the health effects of which may be prevented
through vaccination.
Objectives: This study aims to evaluate the association between stress in nurses and: (1)
insufﬁcient response to inﬂuenza vaccine, assessed one month after vaccination (T1); (2)
the  drop in haemagglutination-inhibition (HAI) antibodies (ab) six months after vaccination
(T6).
Methods: A nested case–control study was carried out with 136 healthy hospital nurses.
Individual interviews, the General Health Questionnaire (GHQ12) and Maslach Burnout Inventory
(MBI-HSS) were applied in order to determine the presence of stress, using the triangulation
method at the beginning of the study (T0). Inﬂuenza vaccine was administered and titres
of  HAI above each strain composing inﬂuenza vaccine before vaccination (T0), at T1 and T6
were assessed.
Results: There was no statistically relevant (5%) relationship between stress and the insufﬁ-
cient immune response to the vaccine at T1. Nevertheless, there was an association between
stress  and the drop in HAI ab AH1 at T6, when we assessed stress by the triangulation method
using  an interview (p = 0.006), GHQ12 (p = 0.045) and combination of criteria (p = 0.001), even
after  multivariate analysis (respectively, p = 0.01, p < 0.05 and p = 0.002). The odds ratios were,
respectively, 3.64, 2.73 and 5.22.
Conclusions: The association we found, between chronic stress and the drop in HAI ab at
T6, corroborates the hypothesis that stress can negatively inﬂuence immune response.
Therefore, it seems reasonable to consider this issue when we implement vaccinationprogrammes for healthcare workers.
© 2013 Escola Nacional de Saúde Pública. Published by Elsevier España, S.L. All rights
reserved.
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Stresse  crónico  e  a  imunidade  à  vacina  contra  a  gripe  em  proﬁssionais
de  saúde
Palavras-chave:
Anticorpos
Proﬁssionais de saúde
Vacina contra a gripe
Stresse
r  e  s  u  m  o
Introduc¸ão: O stresse crónico pode inﬂuenciar a resposta imunitária à vacinac¸ão. Os proﬁs-
sionais de saúde estão expostos a stressores de natureza proﬁssional e ainda a agentes
biológicos cujos efeitos poderão ser prevenidos pela vacinac¸ão.
Objetivos: Estudar a associac¸ão entre a presenc¸a de stresse e (1) a “insuﬁciente” resposta
imunitária à vacina contra a gripe, avaliada um mês após a vacinac¸ão (T1); (2) a reduc¸ão dos
títulos de anticorpos dirigidos às hemaglutininas (HAI) seis meses após a vacinac¸ão (T6).
Métodos: Realizou-se um estudo caso-controlo incorporado num estudo de coortes com a
participac¸ão de 136 enfermeiros hospitalares saudáveis. Realizaram-se entrevistas individu-
ais  e aplicaram-se os questionários The General Health Questionnaire (GHQ12) e Maslach Burnout
Inventory (MBI-HSS) para determinac¸ão da presenc¸a de stresse crónico pelo método da
triangulac¸ão,  no início do estudo (T0). Foi administrada a vacina contra a gripe e determinou-
se  os títulos de HAI dirigidos a cada estirpe componentes da vacina contra a gripe, antes da
vacinac¸ão(T0), em T1 e em T6.
Resultados: Não se encontrou associac¸ão signiﬁcativa (5%) entre a presenc¸a de stress e a
“insuﬁciente” resposta à vacina contra a gripe em T1. Contudo, encontrou-se uma  associac¸ão
entre  a presenc¸a de stress e a diminuic¸ão do título de HAI dirigidos à estirpe A(H1N1) em T6
quando se avaliou a presenc¸a de stresse pelo método da triangulac¸ão usando a entrevista
(p=0,006), o GHQ12 (p=0,045) e a combinac¸ão dos três critérios (p=0,001), que se manteve após
análise multivariada (respetivamente p=0,01, p<0.05 e p=0.002). Os odds ratio ajustados foram
de  3,64, de 2,73 e de 5,22.
Conclusões: A associac¸ão encontrada entre a presenc¸a de stresse crónico e a reduc¸ão do
título de HAI em T6 vem apoiar a hipótese de que o stresse poderá inﬂuenciar negativa-
mente a manutenc¸ão dos títulos de anticorpos, mesmo em indivíduos adultos não idosos.
Assim, parece razoável considerar este aspeto quando se pretende implementar programas
de  vacinac¸ão dirigidos a proﬁssionais de saúde.
© 2013 Escola Nacional de Saúde Pública. Publicado por Elsevier España, S.L. Todos os
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ealthcare workers are exposed to many  stressors, some of
hem related with organisational work conditions and others,
ore speciﬁc to this profession, related with their activity of
aring for the ill.1–3
Chronic stress and burnout seem to be very common in
urses.4–6 For example, López-Castillo and colleagues found
igh levels of emotional disturbance determined by the Gen-
ral Health Questionnaire (GHQ28) in 39% of hospital nurses.7
Amongst the consequences of chronic distress, whether
hey are related or not with work, are the possible effects
n the immune system, including effects on the immune
esponse to vaccination.
Healthcare workers are strongly advised to be vaccinated
gainst inﬂuenza in order to protect themselves against the
isease, reduce staff absenteeism and minimise the risk of
osocomial transmission to the patients they take care of.
accination is a possible model for immune response, test-
ng mostly the humoral immune response. Vaccinated people
evelop antibodies (ab) that bind and neutralise the virus,
n most cases ab against the surface glycoprotein hemagglu-
inin. Those ab can be used as markers of protection against
he disease,8 caused by strains that are similar to the vaccine
omposition.direitos reservados.
According to meta-analysis by Segerstrom and Miller,
chronic exposure to stressors such as taking care of spouses
with dementia, unemployment and suffering from physi-
cal disability is associated with a smaller ab response to
inﬂuenza vaccine.9 Some reviews also suggest that chronic
stress is associated with a smaller ab response to inﬂuenza
vaccine.10–12
Generally speaking, studies evaluating the association
between chronic stress and immune response to inﬂuenza
vaccine showed relatively consistent results in old people.
In those people, chronic exposure to stressors was associ-
ated with chronic anxiety and symptoms of depression and a
lower response to inﬂuenza vaccine, in comparison to a con-
trol group.13–17
The use of a standardized dose of antigen which promotes
a good immune response in most adults, could make it dif-
ﬁcult the detection of the inﬂuence of chronic stress in the
immune response to vaccination in younger adults, with a
robust immune system.
Older people have a weaker immune system, related with
age, so this could be an explanation for the greater con-
sistency of results showing a negative association between
chronic stress and immune response to vaccines in them.
Vedhara and colleagues did not ﬁnd any association between
taking care of spouses with multiple sclerosis and ab
response to inﬂuenza vaccine in adults under the age of 55.18
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However, those adults showed similar stress levels as the con-
trol group.
In younger adults, such as university students, some
studies19–22 found an association between stress, charac-
terised in different ways, and the immune response to
inﬂuenza vaccine (assessed by ab titres or by response rate)
one month after vaccination. However, other studies did not
ﬁnd that association.23–25
Some of the studies found an association between
stress and a drop in ab titres assessed 4–6 months after
vaccination,19–23,25 even in the youngest adults. The drop in
the ab titres associated with stress was only observed against
one strain of vaccine components, suggesting that different
exposures or different past vaccinations can be responsible
for those results.
In an occupational context of healthcare settings, where
healthcare workers are in the labour market (and are there-
fore not very old), but are simultaneously exposed to chronic
stressors and biological risk hazards, it seems important to
study the inﬂuence of stress on immune response to inﬂuenza
vaccine.
Therefore, this study analyses the association between
stress in nurses and: (1) insufﬁcient response to inﬂuenza vac-
cine, assessed one month after vaccination (T1); (2) the drop
in inﬂuenza aemagglutination-inhibition (HAI) ab titres six
months after vaccination (T6), as compared to one month post
vaccination HAI ab titres.
Materials  and  methods
Study  design  and  participants
The study was a nested case–control study, conducted over six
months in a university hospital during the 2007/2008 inﬂuenza
season. Subjects were hospital nurses who  were not taking any
regular medication, including drugs that could affect immu-
nity (such as cancer therapy drugs or corticosteroids). They did
not have any medical condition that could affect the immune
response and they also had no major surgery in the preceding
three months. They did not have a history of drug consump-
tion or alcohol consumption greater than 10 units per week,
nor did they handle citotoxic drugs or work regularly with
ionising radiation (n = 136). The hospital’s Ethics Committee
approved the study and all the participants signed their agree-
ment to participating in it.
One-month and six-month drop-out criteria:
• clinical diagnosis of medical condition that may affect
immune response after the beginning of the study or taking
any regular medication that can affect immunity (assessed
by interview, at T1 and T6);
• workplace changes with regular exposure to ionising radia-
tions or citotoxic drugs handling;
• clinical inﬂuenza symptoms with virus identiﬁcation in
nasal or oropharyngeal swab, during the six months of the
study;
• a rise in HAI Ab titre to A(H1N1), A(H3N2) or B strains six
months after vaccination, as compared with the titres mea-
sured one month after vaccination. Such a rise in HAI Ab a . 2 0 1 4;3 2(1):18–26
titre suggests an exposure to inﬂuenza strains during T1 and
T6 instead of a delayed response to the vaccine.
Stress  assessment
Structured individual interviews were conducted at the begin-
ning of the study (T0) in order to:
• identify socio-demographic characteristics and possible
confoundable variables related with immunity (physical
exercise, nutritional parameters, nutritional supplements,
hours of sleep per day, smoking habits, shift work) and
inﬂuenza vaccination history;
• identify work-related and non-work-related stressors, using
a Likert scale from 1 to 5;
• assess perceived stress, using a Likert scale from 1 to 5;
• identify stress-related behavioural changes or psychoso-
matic symptoms.
We also applied the Portuguese versions of the General
Health Questionnaire (GHQ12) and Maslach Burnout Inventory
(MBI-HSS or MBI) exhaustion scale at the beginning of the
study (T0). Alfa Cronbach for those scales was 0.855 and 0.874
respectively.
In order to assess the presence of chronic stress, we  applied
the triangulation method at T0, as suggested by Cox and
colleagues,26 in four different ways:
• through interviews: we accepted the presence of chronic
stress using interviews if there were identiﬁed stressors
classiﬁed as 4 or 5, plus perceived stress classiﬁed as 4 or 5,
plus at least one behavioural change or one psychosomatic
symptom stress-related;
• through GHQ12: we accepted the presence of chronic stress
using GHQ12 if there were identiﬁed stressors classiﬁed as 4
or 5, plus GHQ12 higher than 2, plus at least one behavioural
change or one psychosomatic symptom stress-related;
• through MBI: we accepted the presence of chronic stress
using MBI if there were identiﬁed stressors classiﬁed as 4 or
5, plus MBI exhaustion scale higher than 24, plus at least one
behavioural change or one psychosomatic symptom stress-
related;
• combination of criteria: we accepted the presence of stress
using combination of criteria if there was stress using inter-
view and stress using GHQ12 or if there was stress using
interview and stress using MBI exhaustion scale.
Vaccination  and  laboratory  procedures
Venous blood was drawn at three stages between October
2007 and April 2008: (i) immediately before inﬂuenza vacci-
nation (T0); (ii) one month following immunisation (T1); and
(iii) six months after T0 (T6).
The samples rested 1 h at ambient temperature follow-
ing centrifugation at 3500 rpm for 10 min. Sera were stored at
−20 ◦C until used. All the samples drawn at T0, T1 and T6 were
processed at the same time and under the same conditions.
A commercially available 2007/2008 trivalent inﬂuenza vac-
cine, with the recommended composition for that season in
North Hemisphere, was administered intramuscularly, in the
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eltoid muscle, during October. All the vaccines belonged to
he same group (AFLUA290AD).
Haemagglutination inhibition reaction was used to assess
peciﬁc HAI ab titre against inﬂuenza A(H1N1), A(H3N2) and
 strains included in the inﬂuenza vaccine, in accordance
ith the World Health Organisation’s manual.27 Immediately
efore the laboratorial procedures, the sera were treated by a
eceptor-Destroying Enzyme (RDE) in order to remove unspeciﬁc
gglutinins and inhibitors.
The reference antigens were diluted to obtain 4 units
gainst haemmaglutinin per 25 l and incubated with the
reated sera samples. Erythrocytes were then added to
he ﬂuid.
HAI Ab titre corresponded to the inverse of the last dilution
f serum that completely inhibited haemagglutination. We
sed progressive dilutions, starting with 1:10 up to 1:20.480.
The serological parameters obtained were:
 HAI Ab titre against inﬂuenza A(H1N1), A(H3N2) and B
strains included in inﬂuenza vaccine, before (T0) and after
vaccination (T1 and T6);
 rise in HAI Ab titre against inﬂuenza A(H1N1), A(H3N2) and B
strains included in inﬂuenza vaccine, assessed one month
after vaccination (compared to HAI Ab titre immediately
before vaccination);
 drop in HAI Ab titre against inﬂuenza A(H1N1), A(H3N2) and
B strains included in inﬂuenza vaccine, between T1 and T6.
eﬁnitions
or analysis at T1 and at T6, we  deﬁned the following groups:
responders at T1 (one month after vaccination): participants
that showed, at T1, at least a fourfold rise in HAI ab titre
compared to the titre before vaccination;
non-responders at T1 (one month after vaccination): partic-
ipants that did not show, at T1, a fourfold rise in HAI ab titre
compared to the titre before vaccination;
HAI ab titre drop group at T6 (six months after vaccination):
participants with at least a fourfold rise in HAI ab titre at T1,
but who  showed a drop in HAI ab titre at T6, as compared to
HAI ab titre at T1;
no change in HAI ab titre group at T6 (six months after vac-
cination): participants with at least a fourfold rise in HAI
ab titre at T1, but with no change in HAI ab titre at T6, as
compared to HAI ab titre at T1.
tatistical  analyses
or dichotomous variables, we  used the Qui-square and Fisher
xact tests and determined the odds ratio.
For numerical variables, we used the Kolmogorov–Smirnov
nd Shapiro–Wilk tests to assess normal distribution in non-
esponders and responders (T1) and in the HAI Ab titre drop
roup and no change in HAI Ab titre group (T6).For normal distributions, the T Student test was used
o compare means, and the Levene test to assess variance
omogeneity. For no normal distributions, we applied the
ann–Whitney test to compare medians. . 2 0 1 4;3  2(1):18–26 21
We  also used the multivariate analysis and determined the
adjusted odds ratio for the confounding variables.
We considered a statistical signiﬁcance of 5%.  All tests were
run in the Statistical Package for Social Sciences – SPSS® software,
version 14.0 for Windows.
Results
We  studied 136 nurses, most of whom were female (83.8%),
Caucasian (96.3%) and did not smoke (77.9%). Their average
age was 33 and the median age was 29 (22–63 years old). Only
one participant was more  than sixty years of age.
More than one half of the participants had been given an
inﬂuenza vaccine shot at least one of the four seasons prior to
the beginning of the study (52.9%), mostly in the year imme-
diately before (44.1%). Nurses included in the study worked
mostly on a shift work basis (70.6%), had a corporal index mass
(kg/m2) between 18.5 and 24.9 (72.1%) and slept at least 7 h per
day (66.2%). The majority did not take vitamin supplements
(86.8%) or ﬁsh oil (98.5%). Only 54.4% did regular physical exer-
cise and 46.3% ate yogurt daily.
Association  between  chronic  stress  and  non-responders
at T1
One month after vaccination (T1), we did not ﬁnd any associ-
ation of statistical signiﬁcance between non-responders for
A(H1N1) virus strain included in the inﬂuenza vaccine and
the presence of chronic stress at T0, assessed in four differ-
ent ways. Similarly, there was also no association between
non-responders for A(H3N2) or non-responders for B strains
included in the inﬂuenza vaccine and chronic stress at T0. To
simplify the table, we named responders or non-responders
for A(H1N1) and for A(H3N2) as responders or non-responders
AH1 and AH3 respectively (Table 1).
Aemagglutination-inhibition  antibodies  titres  at  T0 in
responders  and  non-responders  at  T1
Using the Kolmogorov–Smirnov and Shapiro–Wilk tests, we  found
that there is no normal distribution in non-responders and
responders at T1 for the considered continuous variables
(p < 0.001). Therefore, we  applied the Mann–Whitney test to
compare medians between HAI ab titres at T0 in responders
and non-responders at T1. We found that non-responders
AH1 at T1 had signiﬁcantly higher HAI ab AH1 titres at T0
than responders AH1 at T1. The same happened with non-
responders AH3 at T1 and non-responders B at T1, who  had
signiﬁcantly higher HAI AH3 titres at T0 and HAI B titres at T0
than the corresponding responders (Table 2).
Association  between  chronic  stress  and  drop  in
aemagglutination-inhibition  ab  titres  at  T6
At T6 (six months after vaccination), the presence of stress in
the HAI ab AH1 titre drop group was higher than in the no
change in HAI ab AH1 titre group, when we  assessed stress
by all the considered different ways, being statistically signi-
ﬁcative when we assessed the presence of chronic stress by
22  r e v p o r t s a ú d e p ú b l i c a . 2 0 1 4;3 2(1):18–26
Table 1 – Stress in non-responders and in responders AH1, AH3 and B at T1.
HAI ab groups at T1 Chronic stress
assessment
Stress in
non-responders at T1
Stress in
responders at T1
Statistical analysis
(Qui-square test)
n (%) n (%) OR (95% CI) p
AH1 (n = 135)
Non-responders: 45
Responders: 90
Stress (interview) 28 (62.2) 46 (51.1) 1.575 (0.759–3.272) 0.221
Stress (GHQ12)a 19 (42.2) 44 (48.9) 0.764 (0.371–1.572) 0.464
Stress (MBI)b 16 (35.6) 36 (40.0) 0.828 (0.394–1.738) 0.617
Stress (combination of criteria)c 20 (44.4) 41 (45.6) 0.956 (0.466–1.963) 0.903
AH3 (n = 136)
Non-responders: 50
Responders: 86
Stress (interview) 27 (54.0) 47 (54.7) 0.974 (0.484–1.961) 0.941
Stress (GHQ12)a 20 (40.0) 43 (50.0) 0.667 (0.329–1.351) 0.259
Stress (MBI)b 15 (30.0) 37 (43.0) 0.568 (0.271–1.190) 0.132
Stress (combination criteria)c 20 (40.0) 41 (47.7) 0.732 (0.361–1.483) 0.386
B (n = 135)
Non-responders: 59
Responders: 76
Stress (interview) 31 (52.5) 43 (56.6) 0.850 (0.429–1.683) 0.640
Stress (GHQ12)a 24 (40.7) 39 (51.3) 0.651 (0.327–1.293) 0.219
Stress (MBI)b 22 (37.3) 30 (39.5) 0.912 (0.453–1.836) 0.796
Stress (combination of criteria)c 24 (40.7) 37 (48.7) 0.723 (0.364–1.437) 0.354
OR – odds ratio; 95% CI – 95% conﬁdence interval.
a General Health Questionnaire (GHQ12).
b Maslach Burnout Inventory (MBI).
c Stress (interview and GHQ12) or stress (interview and MBI).
triangulation method at T0 using interviews, GHQ12 and the
combination of the three methods. On the contrary, we did not
ﬁnd any statistically signiﬁcant association between the oth-
ers HAI ab titre drop groups at T6 and the presence of chronic
stress (Table 3).
Association  between  other  possible  confounding  variables
and aemagglutination-inhibition  ab  AH1 titre  drop  group
at T6
Some conditions that can affect immunity could have been
possible confounding factors, when we  considered the asso-
ciation between stress and the HAI ab AH1 titre drop group at
T6. Using the Kolmogorov–Smirnov and Shapiro–Wilk tests, we
found that there is no normal distribution in HAI ab AH1 titre
drop group at T6 and in no change in HAI ab AH1 titre at T6 for
the considered continuous variables (p < 0.001). Therefore, we
applied the Mann–Whitney test to compare their medians.
Table 2 – HAI antibodies AH1, AH3 and B titres at T0 in non-res
HAI antibodies at T0 Non-responders at T1 Re
Md (min–max) M
HAI ab AH1 titres at T0 in
non-responders AH1 (n = 45)
and responders AH1 (n = 90) at
T1
640.0 (80–10,240) 2
HAI ab AH3 titres at T0 in
non-responders AH3 (n = 50)
and responders AH3 (n = 86) at
T1
160.0 (10–5120) 2
HAI ab B titres at T0 in
non-responders B (n = 59)
and responders B (n = 76) at T1
160.0 (20–10,240) 6
Md - median.The statistical analyses did not ﬁnd any signiﬁcant differ-
ence between groups at T6 for the variables (continuous and
dichotomous) taken into consideration (Table 4).
Multivariate  analysis  and  adjusted  odds  ratios  for  stress,
age and  aemagglutination-inhibition  ab  AH1 titres  at  T0
and  T1 considering  aemagglutination-inhibition  ab  AH1
titre  drop  group  at  T6
Stress – assessed by interview, GHQ12 or using the combination
of the three methods – was the exclusive variable associated
with HAI ab AH1 titre drop group at T6, but we  also took the age
variable into consideration in the multivariate analysis. That
option was made because age is a strong factor inﬂuencing
immunity and, in the simple analysis, the median difference
between groups would be different if we considered a conﬁ-
dence level of 90% (instead of 95%).
Furthermore, Beyer and colleagues showed that basal HAI
ab AH1 titres inﬂuence HAI ab AH1 titres one month after
ponders and in responders AH1, AH3 and B at T1.
sponders at T1 Statistical analysis (Mann–Whitney test)
d (min–max) Md differences p
0.0 (10–1280) 620.0 <0001
0.0 (10–1280) 140.0 <0001
0.0 (10–640) 100.0 <0001
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Table 3 – Stress in HAI antibodies titre drop group and in no change in HAI Ab titre group AH1, AH3 and B at T6.
HAI ab groups at T6 Chronic stress
assessment
Stress in HAI ab titre
drop group at T6
Stress in no change in
HAI Ab titre group at T6
Statistical analysis
(Qui-square test)
n (%) n (%) OR (95% CI) p
AH1 (n = 88)
HAI ab titre drop
group: 57
No change in HAI ab
titre group: 31
Stress (interview) 36 (63.2) 10 (32.3) 3.600 (1.427–9.084) 0.006
Stress (GHQ12)a 33 (57.9) 11 (35.5) 2.500 (1.012–6.176) 0.045
Stress (MBI)b 25 (43.9) 10 (32.3) 1.641 (0.656–4.104) 0.288
Stress (combination
of criteria)c
34 (59.6) 7 (22.6) 5.068 (1.875–13.70) 0.001
AH3 (n = 81)
HAI ab titre drop
group: 48
No change in HAI ab
titre group: 33
Stress (interview) 25 (52.1) 21 (63.6) 0.621 (0.251–1.539) 0.302
Stress (GHQ12)a 26 (54.2) (51.5) 1.112 (0.458–2.703) 0.814
Stress (MBI)b 20 (41.7) 16 (48.5) 0.759 (0.311–1.851) 0.544
Stress (combination
of criteria)c
23 (47.9) 18 (54.5) 0.767 (0.315–1.865) 0.558
B (n = 76)
HAI ab titre drop
group: 51
No change in HAI ab
titre group: 25
Stress (interview) 26 (51.0) 17 (68.0) 0.489 (0.179–1.335) 0.160
Stress (GHQ12)a 27 (52.9) 12 (48.0) 1.219 (0.468–3.177) 0.686
Stress (MBI)b 17 (33.3) 13 (52.0) 0.462 (0.174–1.226) 0.118
Stress (combination
of criteria)c
22 (43.1) 15 (60.0) 0.506 (0.191–1.339) 0.167
OR – odds ratio; 95% CI – 95% conﬁdence interval.
a General Health Questionnaire (GHQ12).
b Maslach Burnout Inventory (MBI).
c Stress (interview and GHQ12) or stress (interview and MBI).
Table 4 – Variables distribution (stress not included) in HAI ab AH1 titre drop group at T6 and in no change in HAI ab AH1
titre group AH1 at T6.
Variables HAI ab AH1 titre drop
group at T6 (n = 57)
No  change in HAI ab
AH1 titre group at T6
(n = 31)
Statistical analysis (Fisher test or
Qui-square test or Mann–Whitney
test)
n (%) n (%) OR (95% CI) p
Male gender 5 (8.8) 7 (22.6) 0.330 (0.095–1.145) 0.103a
Caucasian 53 (93.0) 31 (100) 0.631 (0.536–0.743) 0.293a
Shift work 35 (61.4) 23 (74.2) 0.553 (0.211–1.453) 0.250a
Daily sleep hours < 7 20 (35.1) 8 (25.8) 0.643 (0.244–1.699) 0.372b
Smokers 10 (17.5) 9 (29.0) 0.520 (0.185–1.461) 0.211b
Vitamin supplements 10 (17.5) 4 (12.9) 1.436 (0.410–5.025) 0.762a
Fish oil consumption 0 (0.0) 0 (0.0)
Daily consumption of yogurts 27 (47.4) 15 (48.4) 0.960 (0.400–2.304) 0.927b
No regular physical activity 29 (50.9) 11 (35.5) 1.883 (0.765–4.634) 0.166b
Past inﬂuenza vaccine 17 (29.8) 12 (38.7) 0.673 (0.268–1.687) 0.397b
Inﬂuenza vaccine at 2006 14 (24.6) 11 (35.5) 0.592 (0.229–1.533) 0.278b
HAI ab AH1 at T0 ≥ 40 25 (43.9) 17 (54.8) 0.643 (0.267–1.551) 0.325b
Variables HAI ab AH1 titre drop
group at T6 (n = 57)
No change in HAI ab
AH1 titre group at T6
(n = 31)
Statistical analysis (Fisher test or
Qui-square test or Mann–Whitney
test)
Md (min–max) Md (min–max) Md differences p
Age 31.0 (23.0–63.0) 26.0 (22.0–56.0) 5.0 0.072c
Body index mass 22.7 (17.7–37.8) 22.0 (18.0–37.5) 0.7 0.793c
HAI ab AH1 titres at T0 20.0 (10–640) 40.0 (10–1280) −20.0 0.276c
HAI ab AH1 titres at T1 1280.0 (40–20,480) 1280.0 (160–20,480) 0.0 0.265c
Md – median.
a Fisher test.
b Qui Square test.
c Mann–Whitney test.
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Table 5 – Multivaried analysis (multiple logistic regression) for stress (assessed by triangulation method using GHQ12,
using interview and using the combination of the three methods) in HAI ab AH1 titre drop group at T6 considering age,
HAI ab AH1 titres at T0 and at T1.
Chronic stress assessment Considered variables in
multivaried analysis
Statistical  analysis
(multiple logistic
regression)
Adjusted OR (95% CI) p
GHQ12 a
Age 1.038 (0.989–1.089) 0.134
Stress 2.733 (1.039–7.186) 0.042
HAI ab AH1 at T0 0.998 (0.995–1.000) 0.100
HAI ab AH1 at T1 1.000 (1.000–1.000) 0.793
Interview
Age 1.043 (0.994–1.094) 0.083
Stress 3.643 (1.371–9.684) 0.010
HAI ab AH1 at T0 0.999 (0.996–1.001) 0.236
HAI ab AH1 at T1 1.000 (1.000–1.000) 0.987
Combination
of
criteriab
Age 1.044 (0.994–1.096) 0.087
Stress 5.223 (1.828–14.924) 0.002
HAI ab AH1 at T0 0.999 (0.996–1.001) 0.255
HAI ab AH1 at T1 1.000 (1.000–1.000) 0.892
Adjusted OR – adjusted odds ratio; 95% CI – 95% conﬁdence interval.
a General Health Questionnaire (GHQ12).
b Stress (interview and GHQ12) or stress (interview and MBI).
vaccination.28 Therefore, we also considered HAI ab AH1 titres
at T0 and T1 in the multivariate analysis.
We  found that stress, assessed by triangulation method
using GHQ12, using interview and using the combination of
the three methods, maintained the association with HAI ab
AH1 titre drop group at T6. The association between HAI
ab AH1 titre drop group at T6 and the others variables did not
reveal any statistical signiﬁcance (Table 5).
When we  assessed stress by triangulation method using
GHQ12, the model was statistically signiﬁcant (p < 0.029) and
suitable, given that null hypothesis was not rejected in the
Hosmer–Lemeshow test (p < 0.106). The model showed a valid-
ity rate of 65.9.
When we  assessed stress by triangulation method using
interview, the model was statistically signiﬁcant (p < 0.009) and
suitable, given that null hypothesis was not rejected in the
Hosmer–Lemeshow test (p < 0.761). The model showed a valid-
ity rate of 71.6.
When we  assessed stress by triangulation method using
the combination of the three methods, the model was sta-
tistically signiﬁcant (p < 0.002) and suitable, given that null
hypothesis was not rejected in the Hosmer–Lemeshow test
(p < 0.679). The model showed a validity rate of 73.9.
Discussion  and  conclusions
When human beings are exposed to chronic stressors, they
may respond to them with neuroendocrine changes that
include the release of neuropeptides, monoamines and hor-
mones. Most of those substances are able to change the
immune cells behaviour.29Psychological chronic stress can change antibody (ab) pro-
duction and kinetics after vaccination, in particular after the
inﬂuenza vaccine is given to elderly people who take care of
spouses with dementia.9–12Various studies of elderly people have found an asso-
ciation between exposure to a long-term stressor (such as
dementia spouse caregiving) and a small proportion of them
who reached at least ab HAI titres that were fourfold what
they had before ﬂu vaccination, assessed one month after
vaccination.13–15 Bereavement and marriage seem to be asso-
ciated with antibody response to inﬂuenza vaccination in the
elderly as well.17
In our study, as in some other studies involving young
adults,18,23–25 we did not ﬁnd any association between the
presence of chronic stress in nurses and the proportion of
them that reach at least four times the ab HAI titre levels they
had before ﬂu vaccination. On the contrary, other studies have
found an association among perceived distress,19 life events,20
neuroticism21 and loneliness22 and the immune response to
ﬂu vaccination, assessed one month or ﬁve weeks after.
It is possible that methodological issues can explain dis-
crepancies in results veriﬁed in studies with younger groups,
such as: (1) different ways of characterising independent vari-
ables; (2) samples with differing demographic characteristics
and dimensions; (3) differing histories of ﬂu virus exposure.
With respect to the latter issue, our study found that non-
responders had signiﬁcantly higher ab HAI AH1N1, AH3N2 and
B titres at T0 than responder groups. Therefore, as postulated
by Beyer and colleagues,28 ab HAI titres at T0, showed to be an
important confounding variable when studying the relation-
ship between stress and immune response to ﬂu vaccine one
month after vaccination and must be considered.
Nevertheless, we found an association between the pres-
ence of chronic stress (measured in three different ways) and a
drop in ab HAI (AH1N1) at T6. Other studies also found an asso-
ciation between distress,19,25 life events,20 life events weighed
23 21 22with perceived stress, neuroticism, or loneliness and a
drop in ab HAI four to six months after vaccination. Those
associations were found for at least one strain composing the
ﬂu vaccine.
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Our study found a large proportion of nurses with chronic
tress in the HAI ab AH1 titre drop group at T6, as compared
o the no change in HAI Ab AH1 titre group at T6, when we
easured stress by triangulation method, using interview or
HQ12 to assess perceived stress, and using the combination
f the three methods (as described in the methods section). We
id not ﬁnd any statistically signiﬁcant association when we
ssessed the presence of stress by the triangulation method
ut using the MBI  exhaustion scale to measure perceived
tress. A possible explanation is the fact that the MBI exhaus-
ion scale measures speciﬁcally work-related stress and the
ossible immunologic repercussions of chronic stress seem to
e independent of the stress source.
As described in other studies,19–23,25 the association
etween stress and a drop in ab HAI at T6 did not occur for
ll the vaccine strains components.
Strain novelty can be an important factor in that analy-
is, as argued by other authors.15,20 Pressman and colleagues,
or example, only found an association between stress and
 drop in HAI ab, four months after vaccination, for a strain
hat was not included in previous vaccinations the partici-
ants received.25 In our study, the exclusive strain that was
ot included in ﬂu vaccines in the three preceding years
as the A(H1N1) strain.
In Portugal the predominant circulating strains with high
u activity since 1990 have been A(H3N2) and B. From 1990 to
he beginning of the study, the A(H1N1) strain was only pre-
ominant in 2005, simultaneously with strain B, and 2005 was
 year with very low ﬂu activity.30 We  also know that A strains
ndergo more  drift mutations than B stains,31 so this can con-
ribute to their being a relative novelty for the participants’
mmune system.
Finally, in our study, the A(H1N1) inﬂuenza strain proved to
e the most immunogenic one, showing a rise in the HAI Ab
itre geometric mean of 11.1. A (H3N2) and B strains showed
ises of 6.2 and 4.6 times, respectively, between T0 and T1.
t is possible that the best immunogenicity observed for the
 (H1N1) strain was related with the fact that some partici-
ants had had a primary infection with an A (H1N1) strain, so
he response to A (H1N1) antigens have been more  robust in
hem.32 That could be a factor that may inﬂuence the detec-
ion of the association between stress and drops in HAI ab after
 period of time.
Given that our sample was not a randomised sample
ecause it depended on nurses voluntarily being vaccinated
nd participating in the study, we analysed distribution dif-
erences for some variables in the HAI ab AH1 titre drop group
t T6 and the no change in HAI Ab AH1 titre group at T6 that are
ot included in drop out criteria. As there are a lot of variables
or which we  do not yet know if they can inﬂuence immu-
ity, we  studied those that are most referred to in the relevant
iterature.33
We  did not ﬁnd any differences in the distribution of
he studied variables in the two groups at T6. Nevertheless,
e decided to include ab AH1 titres at T0, ab AH1 titres at
1 and age in multiple logistic regression. The reason for
ncluding the ﬁrst two variables was the strong suggestion in
iterature that they can inﬂuence ab titres after vaccination
immune response),28 even though we  found no references to
he inﬂuence they have on a drop in titres six months after . 2 0 1 4;3  2(1):18–26 25
ﬂu vaccination. Age is strongly related with immunity33 but
we did not ﬁnd any difference in terms of age between the
two groups considered at T6 at the signiﬁcance level we  con-
sidered (5%). If we  considered a signiﬁcance level of 10% the
result would be different. Hence, we also included age in
the multivariate analysis.
After the multivariate analysis, we  still found an associ-
ation with statistical signiﬁcance between the presence of
chronic stress and the HAI ab AH1 titre drop group at T6, when
we assessed stress in three different ways, all of them using
the triangulation method, as suggested by Cox and colleagues,
as a good way of measuring stress.26 Therefore, the relation-
ship that we  found between chronic stress and a drop in HAI ab
at T6 supports the thesis that stress can negatively inﬂuence
HAI ab titres some months after ﬂu vaccination even in people
in adults under the age of 60. As we could notice, this is the ﬁrst
study assessing the association between chronic stress and
immune response to inﬂuenza vaccine in healthcare workers,
who is an important target group for inﬂuenza vaccine. There-
fore, in an occupational health environment, it is reasonable
to consider the possible interference of chronic stress with ab
titres when we  implement vaccination programmes to prevent
biological occupational risks.
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